Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 325 to 328 of 328 entries
Sorted by: Best Match Show Resources per page
Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone.

Journal of clinical anesthesia

Grelet T, Besch G, Puyraveau M, Assila L, Pascual M, Ferreira D, Vettoretti L, Pili-Floury S, Samain E, Berthier F.
PMID: 34332494
J Clin Anesth. 2021 Dec;75:110468. doi: 10.1016/j.jclinane.2021.110468. Epub 2021 Jul 28.

No abstract available.

Cite
Grelet T, Besch G, Puyraveau M, et al. Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone. J Clin Anesth. 2021;75:110468doi: 10.1016/j.jclinane.2021.110468.
Grelet, T., Besch, G., Puyraveau, M., Assila, L., Pascual, M., Ferreira, D., Vettoretti, L., Pili-Floury, S., Samain, E., & Berthier, F. (2021). Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone. Journal of clinical anesthesia, 75110468. https://doi.org/10.1016/j.jclinane.2021.110468
Grelet, Tommy, et al. "Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone." Journal of clinical anesthesia vol. 75 (2021): 110468. doi: https://doi.org/10.1016/j.jclinane.2021.110468
Grelet T, Besch G, Puyraveau M, Assila L, Pascual M, Ferreira D, Vettoretti L, Pili-Floury S, Samain E, Berthier F. Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone. J Clin Anesth. 2021 Dec;75:110468. doi: 10.1016/j.jclinane.2021.110468. Epub 2021 Jul 28. PMID: 34332494.
Copy Download .nbib Format: NLM
Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding.

Indian journal of clinical biochemistry : IJCB

Graham JW, Paul SP, Mulholland S, Tran SC, Butler CL, Mankiewitz RD, Beech G.
PMID: 33867718
Indian J Clin Biochem. 2021 Apr;36(2):242-243. doi: 10.1007/s12291-019-00865-6. Epub 2019 Dec 04.

No abstract available.

Cite
Graham JW, Paul SP, Mulholland S, et al. Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding. Indian J Clin Biochem. 2019;36(2):242-243doi: 10.1007/s12291-019-00865-6.
Graham, J. W., Paul, S. P., Mulholland, S., Tran, S. C., Butler, C. L., Mankiewitz, R. D., & Beech, G. (2021). Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding. Indian journal of clinical biochemistry : IJCB, 36(2), 242-243. https://doi.org/10.1007/s12291-019-00865-6
Graham, Jonathan Wayland, et al. "Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding." Indian journal of clinical biochemistry : IJCB vol. 36,2 (2021): 242-243. doi: https://doi.org/10.1007/s12291-019-00865-6
Graham JW, Paul SP, Mulholland S, Tran SC, Butler CL, Mankiewitz RD, Beech G. Investigating Prolonged Neonatal Jaundice: A Staged Approach is Superior and Conducive to Breastfeeding. Indian J Clin Biochem. 2021 Apr;36(2):242-243. doi: 10.1007/s12291-019-00865-6. Epub 2019 Dec 04. PMID: 33867718; PMCID: PMC7994485.
Copy Download .nbib Format: NLM
Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device.

Preventive medicine reports

Tatzber F, Resch U, Lindschinger M, Cvirn G, Wonisch W.
PMID: 33282639
Prev Med Rep. 2020 Dec;20:101270. doi: 10.1016/j.pmedr.2020.101270. Epub 2020 Nov 28.

The filtering facepiece operates through filtration without the ability to kill the viruses. If the filtration might be combined with antiviral agents simultaneously in the masks, this would be much more efficient during the use of these masks and...

Cite
Tatzber F, Resch U, Lindschinger M, et al. Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device. Prev Med Rep. 2020;20:101270doi: 10.1016/j.pmedr.2020.101270.
Tatzber, F., Resch, U., Lindschinger, M., Cvirn, G., & Wonisch, W. (2020). Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device. Preventive medicine reports, 20101270. https://doi.org/10.1016/j.pmedr.2020.101270
Tatzber, Franz, et al. "Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device." Preventive medicine reports vol. 20 (2020): 101270. doi: https://doi.org/10.1016/j.pmedr.2020.101270
Tatzber F, Resch U, Lindschinger M, Cvirn G, Wonisch W. Improved protection of filtering facepiece through inactivation of pathogens by hypertonic salt solutions - A possible COVID-19 prevention device. Prev Med Rep. 2020 Dec;20:101270. doi: 10.1016/j.pmedr.2020.101270. Epub 2020 Nov 28. PMID: 33282639; PMCID: PMC7695550.
Copy Download .nbib Format: NLM
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.

Critical reviews in oncology/hematology

Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF.
PMID: 34902554
Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10.

OBJECTIVE: To determine the oncologic and toxicity outcomes of adjuvant immunotherapy with immune checkpoint inhibitors (ICIs) compared to adjuvant chemotherapy in patients treated with radical surgery for urothelial carcinoma (UC).METHODS: We used the Bayesian approach in the network meta-analysis...

Cite
Laukhtina E, Sari Motlagh R, Mori K, et al. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Crit Rev Oncol Hematol. 2021;169:103570doi: 10.1016/j.critrevonc.2021.103570.
Laukhtina, E., Sari Motlagh, R., Mori, K., Katayama, S., Rajwa, P., Yanagisawa, T., Quhal, F., Mostafaei, H., Grossmann, N. C., König, F., Aydh, A., Pradere, B., Resch, I., Merseburger, A. S., Enikeev, D., & Shariat, S. F. (2022). Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Critical reviews in oncology/hematology, 169103570. https://doi.org/10.1016/j.critrevonc.2021.103570
Laukhtina, Ekaterina, et al. "Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes." Critical reviews in oncology/hematology vol. 169 (2022): 103570. doi: https://doi.org/10.1016/j.critrevonc.2021.103570
Laukhtina E, Sari Motlagh R, Mori K, Katayama S, Rajwa P, Yanagisawa T, Quhal F, Mostafaei H, Grossmann NC, König F, Aydh A, Pradere B, Resch I, Merseburger AS, Enikeev D, Shariat SF. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. Crit Rev Oncol Hematol. 2022 Jan;169:103570. doi: 10.1016/j.critrevonc.2021.103570. Epub 2021 Dec 10. PMID: 34902554.
Copy Download .nbib Format: NLM
Showing 325 to 328 of 328 entries